Who is sponsoring NCT05590936?

NCT05590936 is sponsored by University of Thessaly.

What drugs are being tested in NCT05590936?

Interventions in NCT05590936: Dimenhydrinate Tablets, Ondansetron iv.

What condition does NCT05590936 study?

NCT05590936 studies PONV in Laparoscopic Cholocystectomies.

Is NCT05590936 still recruiting?

NCT05590936 is currently completed. Last updated 8 December 2022.

Last reviewed 2022-12-08 · How we verify

NCT05590936: DONV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dimenydrinate vs Ondansetron for PONV (DONV)

Completed NA Last updated 8 December 2022

What this trial tests

NA trial testing Dimenhydrinate Tablets in PONV in Laparoscopic Cholocystectomies in 190 participants. Completed in 7 December 2022.

Timeline

1 January 2018

Primary endpoint
7 December 2022

7 December 2022

Quick facts

Lead sponsor	University of Thessaly
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	190
Start date	1 January 2018
Primary completion	7 December 2022
Estimated completion	7 December 2022
Sites	1 location across Greece

Drugs / interventions tested

Dimenhydrinate Tablets — full drug profile →
Ondansetron iv — full drug profile →

Conditions studied

PONV in Laparoscopic Cholocystectomies — all drugs for PONV in Laparoscopic Cholocystectomies →

Sponsor

University of Thessaly

Who can join

Adults 18 to 75, any sex, with PONV in Laparoscopic Cholocystectomies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate the impact of dimenydrinate (H1-receptor antagonist) versus ondansetron (HT3-receptor antagonist) in postoperative nausea and vomiting, in surgery-related preoperative stress and in the incidence of postoperative complications that could lengthen the LOS in PACU and/or the overall LOS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Thessaly trials

Trials by the same sponsor.

NCT07376187 — Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases · NA · not yet recruiting
NCT07496151 — The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy. · NA · not yet recruiting
NCT07420309 — Colonoscopy TRaining With or Without Artificial INtelligence Among Endoscopy Residents · NA · recruiting
NCT07341711 — Long-term Adaptations of Skeletal Muscle After Hybrid Training. · NA · not yet recruiting
NCT07380009 — Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Rece · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05590936 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Thessaly
Last refreshed: 8 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05590936.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing